These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36617975)

  • 1. RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer.
    Nakamura S; Kitazawa M; Miyagawa Y; Koyama M; Miyazaki S; Hondo N; Muranaka F; Tokumaru S; Yamamoto Y; Ehara T; Matsumura T; Takeoka M; Soejima Y
    Technol Cancer Res Treat; 2023; 22():15330338221146024. PubMed ID: 36617975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.
    Fujisawa M; Sakata-Yanagimoto M; Nishizawa S; Komori D; Gershon P; Kiryu M; Tanzima S; Fukumoto K; Enami T; Muratani M; Yoshida K; Ogawa S; Matsue K; Nakamura N; Takeuchi K; Izutsu K; Fujimoto K; Teshima T; Miyoshi H; Gaulard P; Ohshima K; Chiba S
    Leukemia; 2018 Mar; 32(3):694-702. PubMed ID: 28832024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model.
    Nishizawa T; Nakano K; Fujii E; Komura D; Kuroiwa Y; Ishimaru C; Monnai M; Aburatani H; Ishikawa S; Suzuki M
    Oncol Rep; 2019 Nov; 42(5):1745-1754. PubMed ID: 31485674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
    Huang W; Zhao S; Zhang C; Li Z; Ge S; Lian B; Feng H; Wang K; Xu R; Ji J; Gao J; Shi W; Shen L
    Aging (Albany NY); 2020 Dec; 13(1):714-734. PubMed ID: 33288739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.
    Korourian A; Roudi R; Shariftabrizi A; Madjd Z
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1842-1847. PubMed ID: 28836853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion.
    Bartolomé RA; Molina-Ortiz I; Samaniego R; Sánchez-Mateos P; Bustelo XR; Teixidó J
    Cancer Res; 2006 Jan; 66(1):248-58. PubMed ID: 16397238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
    Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
    Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
    Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
    Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility.
    Matsuoka T; Yashiro M; Kato Y; Shinto O; Kashiwagi S; Hirakawa K
    Clin Exp Metastasis; 2011 Oct; 28(7):627-36. PubMed ID: 21667311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of gastric cancer cell growth and invasion through siRNA-mediated knockdown of guanine nucleotide exchange factor Vav3.
    Tan B; Li Y; Zhao Q; Fan L; Wang D; Liu Y
    Tumour Biol; 2014 Feb; 35(2):1481-8. PubMed ID: 24072493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
    Liu BP; Burridge K
    Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Met-dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis.
    Liu J; Li S; Chen S; Chen S; Geng Q; Xu D
    J Pathol; 2019 Sep; 249(1):126-136. PubMed ID: 31056743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHOA
    Schaefer A; Hodge RG; Zhang H; Hobbs GA; Dilly J; Huynh MV; Goodwin CM; Zhang F; Diehl JN; Pierobon M; Baldelli E; Javaid S; Guthrie K; Rashid NU; Petricoin EF; Cox AD; Hahn WC; Aguirre AJ; Bass AJ; Der CJ
    Sci Signal; 2023 Dec; 16(816):eadg5289. PubMed ID: 38113333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-Function
    Zhang H; Schaefer A; Wang Y; Hodge RG; Blake DR; Diehl JN; Papageorge AG; Stachler MD; Liao J; Zhou J; Wu Z; Akarca FG; de Klerk LK; Derks S; Pierobon M; Hoadley KA; Wang TC; Church G; Wong KK; Petricoin EF; Cox AD; Lowy DR; Der CJ; Bass AJ
    Cancer Discov; 2020 Feb; 10(2):288-305. PubMed ID: 31771969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suppressive effect of Rho kinase inhibitor, Y-27632, on oncogenic Ras/RhoA induced invasion/migration of human bladder cancer TSGH cells.
    Chang HR; Huang HP; Kao YL; Chen SL; Wu SW; Hung TW; Lian JD; Wang CJ
    Chem Biol Interact; 2010 Jan; 183(1):172-80. PubMed ID: 19896475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity.
    Liu N; Bi F; Pan Y; Sun L; Xue Y; Shi Y; Yao X; Zheng Y; Fan D
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6239-47. PubMed ID: 15448013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer.
    Yan G; Zou R; Chen Z; Fan B; Wang Z; Wang Y; Yin X; Zhang D; Tong L; Yang F; Jiang W; Fu W; Zheng J; Bergo MO; Dalin M; Zheng J; Chen S; Zhou J
    Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):682-90. PubMed ID: 25001480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of BMX-ARHGAP fusion gene inhibits epithelial-mesenchymal transition in gastric cancer cells via RhoA-mediated blockade of JAK/STAT axis.
    Xu XF; Wang JJ; Ding L; Ye JS; Huang LJ; Tao L; Gao F; Ji Y
    J Cell Biochem; 2019 Jan; 120(1):439-451. PubMed ID: 30216523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton.
    Tang Z; Zhang N; Di W; Li W
    Oncol Rep; 2015 Mar; 33(3):1411-7. PubMed ID: 25607473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eupafolin regulates non-small-cell lung cancer cell proliferation,migration, and invasion by suppressing MMP9 and RhoA via FAK/PI3K/AKT signaling pathway.
    Wang X; Huang M; Xie W; Ding Q; Wang T
    J Biosci; 2023; 48():. PubMed ID: 36695419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.